Proactive Investors - Run By Investors For Investors

IQ-AI makes first Imaging Biometrics software sale to South Korea, updates on StoneChecker software progress

Its distributor, Korea Computer ISG has sold a suite of Imaging Biometrics neuroradiology software to Haeundae Paik Hospital in Busan, which will be installed in March 2019
Checking stones
IQ-AI said it continues to seek business development relationships that will expose its products to a broader audience worldwide

IQ-AI Ltd (LON:IQAI) has made the first sale of its Imaging Biometrics (IB) software to South Korea, while its StoneChecker software has received a Medical Information Bulletin from the UK's National Institute for Health and Care Excellence (NICE).

The London main market-listed company said its distributor, Korea Computer ISG has sold a suite of Imaging Biometrics neuroradiology software to Haeundae Paik Hospital in Busan, South Korea, which will be installed in March 2019.

READ: IQ-AI expecting the FDA to complete its review of Stonechecker by end of first quarter 2019

It added that the sale comprises IB's latest offering of IB Server (IB Neuro, IB Delta Suite, IB Diffusion and IB DCE, IB Rad Tech plug in).

IQ-AI also announced that UK's National Institute for Health and Care Excellence has issued a Medical Information Bulletin on its StoneChecker Software, having evaluated the clinical value and cost-effectiveness of the product.

The group said the StoneChecker software's regulatory approval process is continuing in the USA, with the recent and continuing threat of a government shutdown having delayed the review of the product.

However, the company added, it is in frequent contact with Food and Drug Administration, updating and amending the pending application to meet the FDA's requirements.

Meanwhile, IQ-AI said it continues to seek business development relationships that will expose its products to a broader audience worldwide.

It added that several marketing and distribution alliances are under active consideration with these to be evaluated, and if appropriate, will be announced in the next few months.

View full IQAI profile View Profile

IQ-AI Limited Timeline

Related Articles

Drain
December 18 2018
MetroRod has been in operation for 30 years but only became a franchise relatively recently
H&T
December 03 2018
“I think customers are seeing that we do offer value and that really is the answer,” said chief executive John Nichols
Scans and MRI
November 28 2018
The firm's subsidiary, Imaging Biometrics, recently appointed a South Korean distributor a few weeks after receiving the first commercial order for its StoneChecker technology

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use